Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Vaccine Effectiveness”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01499914
What this trial is testing

Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination

Who this might be right for
Cystic Fibrosis With Gastrointestinal Manifestation
Assistance Publique - Hôpitaux de Paris 439
Large-scale testing (Phase 3)Study completedNCT02572817
What this trial is testing

Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A

Who this might be right for
Influenza A Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 138
Not applicableStudy completedNCT01282177
What this trial is testing

Influenza Vaccine Safety and Effectiveness in Healthcare Providers

Who this might be right for
Influenza
Dalhousie University 1,143
Post-approval studies (Phase 4)Study completedNCT00934245
What this trial is testing

Direct and Indirect Protection by Influenza Vaccine Given to Children in India

Who this might be right for
Influenza
Wayne Sullender, M.D. 4,598
Testing effectiveness (Phase 2)Ended earlyNCT05567783
What this trial is testing

Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

Who this might be right for
Influenza A
Vir Biotechnology, Inc. 2,977
Large-scale testing (Phase 3)Study completedNCT03969212
What this trial is testing

Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households

Who this might be right for
Influenza
Hoffmann-La Roche 4,138
Post-approval studies (Phase 4)Study completedNCT01298102
What this trial is testing

Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Disease Patients

Who this might be right for
Decreased Immunologic Activity [PE]InfluenzaRejection
Erasme University Hospital 185
Post-approval studies (Phase 4)Study completedNCT00961337
What this trial is testing

Evaluation of a School-based Influenza Vaccination Program

Who this might be right for
InfluenzaInfluenza Vaccines
Centers for Disease Control, Taiwan 7,854
Very early researchStudy completedNCT03833271
What this trial is testing

The Efficacy of Influenza Vaccine Program in Children With Juvenile Idiopathic Arthritis. A Single Centre Results From Hungary

Who this might be right for
Juvenile Idiopathic Arthritis
University of Pecs 62
Not applicableStudy completedNCT04723771
What this trial is testing

Influenza Vaccine Effectiveness of a Quadrivalent Vaccine in Pregnant Women and Young Infants, 2019-2020

Who this might be right for
Influenza in Human
University of Athens 949
Not applicableStudy completedNCT04413929
What this trial is testing

Study on Safety and Effectiveness of Ergoferon in the Treatment of Flu / ARVI in Outpatients.

Who this might be right for
Viral Respiratory Infection
Materia Medica Holding 8,411
Testing effectiveness (Phase 2)Study completedNCT01938352
What this trial is testing

Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge

Who this might be right for
Influenza
Crucell Holland BV 22
Post-approval studies (Phase 4)Study completedNCT02748785
What this trial is testing

MTX Discontinuation and Vaccine Response

Who this might be right for
Arthritis, Rheumatoid
Seoul National University Hospital 277
Testing effectiveness (Phase 2)UnknownNCT00294788
What this trial is testing

Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines

Who this might be right for
Influenza
Probiomics Ltd 300
Large-scale testing (Phase 3)Study completedNCT00128167
What this trial is testing

Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age

Who this might be right for
Influenza
MedImmune LLC 8,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT07371650
What this trial is testing

This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza

Who this might be right for
Influenza
Traws Pharma, Inc. 105
Testing effectiveness (Phase 2)Study completedNCT01685372
What this trial is testing

Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

Who this might be right for
Solid Organ Transplant Recipient (Liver, Kidney, Heart)Rheumatologic DisorderHuman Immunodeficiency Virus (HIV)+2 more
University of Colorado, Denver 16
Not applicableUnknownNCT05582239
What this trial is testing

Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults

Who this might be right for
Severe Acute Respiratory Infection (SARI)InfluenzaCOVID-19
ANRS, Emerging Infectious Diseases 2,400
Large-scale testing (Phase 3)Study completedNCT03684044
What this trial is testing

Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza

Who this might be right for
Influenza
Hoffmann-La Roche 363
Large-scale testing (Phase 3)Study completedNCT05273619
What this trial is testing

Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Who this might be right for
Common ColdAcute Respiratory InfectionInfluenza, Human
Valenta Pharm JSC 250
Next Page